Samar S Khalaf
Overview
Explore the profile of Samar S Khalaf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fahmy M, Sadek M, Abdou K, El-Dessouki A, El-Shiekh R, Khalaf S
Inflammopharmacology
. 2025 Mar;
PMID: 40056319
Medicinal herbs continue to play an important part in modern drugs and healthcare because customers think that most of them have fewer or milder side effects than traditional modern medicines....
2.
Fahmy M, Khalaf S, Elrayess R
Eur J Pharmacol
. 2024 Aug;
980:176878.
PMID: 39127301
Parkinson's disease (PD) is an idiopathic disease caused by the loss or degeneration of the dopaminergic (dopamine-producing) neurons in the brain and characterized by various inflammatory and apoptotic responses in...
3.
Mohamed Y, Abdelghaffar M, Khalaf S, Amin A, Mostafa M, Harb O, et al.
J Med Case Rep
. 2024 Jun;
18(1):286.
PMID: 38907357
Background: Due to rarity of duodenal GISTs, clinicians have few information about its clinical features, diagnosis, management and prognosis. Case Report: We report a case of promptly diagnosed duodenal GIST...
4.
Fahmy M, Khalaf S, Yassen N, Sayed R
Int Immunopharmacol
. 2023 Dec;
127:111457.
PMID: 38160566
Cisplatin is a highly effective antitumor agent, but its clinical use is limited due to critical adverse reactions including acute kidney injury (AKI). Nicorandil is an approved antianginal agent decreasing...
5.
Khalaf S, Shalaby O, Hassan A, El-Kherbetawy M, Mehanna E
J Tradit Complement Med
. 2023 Jul;
13(4):397-407.
PMID: 37396158
Background And Aim: () is an imperative plant with many medicinal uses. The current study aimed to investigate the protective effects of the stem bark of and its fractions in...
6.
Mehanna E, Khalaf S, Mesbah N, Abo-Elmatty D, Hafez M
Life Sci
. 2021 Oct;
288:120098.
PMID: 34715137
Aim: Nephrotoxicity is the major limiting factor for the clinical use of vancomycin (VCM) for treatment against multi-resistant Gram-positive bacteria. The present research aimed to investigate the ability of selenium...
7.
Khalaf S, Hafez M, Mehanna E, Mesbah N, Abo-Elmatty D
Naunyn Schmiedebergs Arch Pharmacol
. 2019 Feb;
392(6):685-695.
PMID: 30759264
There is increasing evidence of a link between type 2 diabetes mellitus (T2DM) and cognitive decline. T2DM has been recognized as a risk factor for Alzheimer's disease (AD). The aim...